Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome

Authors:

Abstract
No abstract available
Funding Information
  • Audentes Therapeutics

This publication has 18 references indexed in Scilit: